HRQoL, vulnerability, and MDS disease risk Except for FACT-G and PROMIS Fatigue, a significant trend of worsening HRQoL with worse MDS or MDS/MPN disease prognosis was identified for all overall HRQoL scores, with decreasing EQ-5D-5L mean scores of 73.4 (95% CI, 70.2-76.5), 72.7 (95% CI, 67.5-77.8), and 64.1 (95% CI, 59.1-69.1) for low-, intermediate-, and high-risk MDS or MDS/MPN, respectively ( P = .005, Figure 3 ; supplemental Table 4 ).
← all excerpts
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study.
1
—
—